pre eclampsia - Nursing Case Study
Pathophysiology
• Primary mechanism: Abnormal placentation leads to poor remodeling of the spiral arteries, resulting in decreased placental perfusion and ischemia, which trigger systemic endothelial dysfunction.
• Secondary mechanism: Endothelial dysfunction causes increased vascular permeability and vasoconstriction, leading to hypertension and proteinuria as key clinical manifestations.
• Key complication: The systemic endothelial damage can progress to multi-organ involvement, increasing the risk of complications such as eclampsia, HELLP syndrome, and adverse fetal outcomes.
Patient Profile
Demographics:
32-year-old female, office manager
History:
• Key past medical history: Hypertension diagnosed 2 years ago
• Current medications: Labetalol 200 mg twice daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe headache and visual disturbances
• Key symptoms: Swelling in hands and feet, upper right abdominal pain, nausea
• Vital signs: Blood pressure 160/110 mmHg, heart rate 95 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F
Section 1
Upon further assessment, the patient's symptoms have intensified, prompting the healthcare team to conduct an urgent evaluation. A more detailed examination reveals that the patient's headache is persistent and severe, unrelieved by rest or hydration. The visual disturbances have evolved into scotomas, and she reports episodic flashes of light. Her swelling has increased, now extending to the face, and her upper right abdominal pain is more pronounced. The patient’s urine dipstick test reveals 3+ proteinuria, confirming significant protein loss. Her reflexes are brisk, with a noted 3+ deep tendon reflexes, suggesting increased neuromuscular irritability.
Laboratory tests return showing elevated liver enzymes (AST 110 IU/L, ALT 98 IU/L) and a low platelet count of 95,000/mm³. These findings are alarming and suggest the development of HELLP syndrome, a serious complication of preeclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count. The fetal non-stress test indicates some fetal distress, with late decelerations in the fetal heart rate, necessitating continuous fetal monitoring.
The healthcare team recognizes the progression of the patient's condition and discusses potential interventions. Given the risk of further complications such as eclampsia or placental abruption, the team considers the need for expedited delivery. A discussion with the patient and her family about the current status and potential risks leads to the decision to proceed with a cesarean section to ensure maternal and fetal safety. This decision underscores the importance of timely intervention in managing preeclampsia with severe features and avoiding further deterioration.
Section 2
Following the decision to proceed with an emergency cesarean section, the healthcare team swiftly prepares the patient for the procedure. As the patient is transferred to the operating room, her vital signs are closely monitored. Her blood pressure remains dangerously high at 170/110 mmHg despite initial attempts at pharmacologic management with intravenous labetalol. The patient’s heart rate is elevated at 105 beats per minute, and respiratory rate is 24 breaths per minute, indicating increased stress and anxiety. Oxygen saturation remains stable at 95% on room air, but the healthcare team initiates supplemental oxygen to ensure optimal fetal oxygenation.
Intraoperatively, the team observes that the patient's blood loss is more significant than anticipated, raising concerns about coagulopathy, likely exacerbated by her low platelet count. The anesthesiologist administers additional intravenous fluids and considers a transfusion of platelets to manage potential bleeding risks. Despite these challenges, the cesarean section progresses, and a male infant is delivered. The newborn requires immediate attention from the neonatal team due to initial respiratory distress, which is quickly addressed with positive pressure ventilation. The Apgar scores at 1 and 5 minutes are 6 and 8, respectively, indicating a positive response to resuscitation efforts.
Postoperatively, the patient is transferred to the intensive care unit for close monitoring. Her blood pressure remains elevated, and she is continued on a magnesium sulfate infusion to prevent seizures, addressing the risk of eclampsia. The healthcare team remains vigilant for any signs of further complications, such as worsening HELLP syndrome or postpartum hemorrhage. The patient is informed of her condition, and a multidisciplinary team, including obstetrics, anesthesia, and internal medicine, coordinates ongoing care. This careful management underscores the importance of proactive intervention and multidisciplinary collaboration in the face of severe preeclampsia and its complications.
Section 3
As the patient settles into the intensive care unit, the healthcare team conducts an initial assessment to establish a baseline for her postoperative recovery. Her vital signs indicate persistent hypertension, with a blood pressure reading of 165/105 mmHg, despite the ongoing magnesium sulfate infusion. Her heart rate has decreased slightly to 98 beats per minute, but she remains tachypneic with a respiratory rate of 22 breaths per minute. The patient reports feeling lethargic and slightly disoriented, prompting the team to assess her neurological status closely.
The laboratory results from the blood work drawn upon her ICU admission reveal a worsening trend in her liver enzymes, with AST at 125 IU/L and ALT at 110 IU/L, suggesting progression towards HELLP syndrome. Her platelet count has dropped to 85,000/mm³, exacerbating concerns about her coagulation status. The team discusses the potential need for further interventions, including platelet transfusion, to stabilize her condition and prevent further bleeding complications. Her kidney function tests are stable, with a serum creatinine of 0.9 mg/dL, providing some reassurance regarding her renal status.
In response to these findings, the multidisciplinary team revisits the patient's management plan. They decide to increase the frequency of her vital sign monitoring and repeat laboratory tests every four hours to detect any rapid changes. The team also considers adjusting her antihypertensive regimen to better control her blood pressure while ensuring the safe continuation of magnesium sulfate therapy. The patient is informed of her current status, and the plan is communicated clearly to her and her family to ensure understanding and cooperation. This careful, ongoing assessment and adjustment of the treatment plan highlight the need for vigilant monitoring and readiness to intervene in the dynamic setting of severe preeclampsia with associated complications.
Section 4
As the ICU team continues to monitor the patient, a new set of diagnostic results reveals concerning changes in her condition. Her blood pressure remains elevated, despite adjustments to her antihypertensive regimen, now reading 170/110 mmHg. The magnesium sulfate infusion is maintained, but the patient begins to exhibit signs of magnesium toxicity, including diminished deep tendon reflexes and increased respiratory depression, with her respiratory rate dropping to 18 breaths per minute. The team immediately reduces the magnesium sulfate dosage and administers calcium gluconate as an antidote to counteract the toxicity, while simultaneously reevaluating her blood pressure management strategy.
The repeat laboratory tests show further deterioration in her liver function, with AST rising to 145 IU/L and ALT to 130 IU/L, confirming the progression of HELLP syndrome. Her platelet count has decreased further to 78,000/mm³, heightening the risk of significant bleeding complications. The decision is made to proceed with a platelet transfusion to stabilize her coagulation status. Additionally, a peripheral blood smear is ordered to examine for schistocytes, which could indicate ongoing hemolysis, a component of HELLP syndrome. The patient is closely monitored for any signs of bleeding, particularly in the context of potential surgical sites and mucosal surfaces.
In light of these developments, the multidisciplinary team intensifies their focus on balancing the management of her hypertension while addressing the complications arising from HELLP syndrome. The patient is closely observed for any signs of neurological changes or worsening disorientation, given the risk of cerebral involvement in severe preeclampsia. The team remains vigilant, ready to implement further interventions as needed, ensuring that both the patient and her family are kept informed and involved in the ongoing care process. This dynamic and responsive approach underscores the critical importance of continuous assessment and timely intervention in managing complex preeclampsia cases with complications such as HELLP syndrome.
Section 5
As the ICU team continues to manage the patient's complex condition, a new complication arises. The patient's respiratory status begins to decline further, evidenced by a reduction in her oxygen saturation levels to 88% on room air. Despite the initial intervention with calcium gluconate to counteract magnesium toxicity, her respiratory rate, now at 16 breaths per minute, raises concerns of potential hypoventilation. The team promptly initiates supplemental oxygen therapy via nasal cannula, increasing her oxygen saturation to 94%. A chest X-ray is ordered to rule out any pulmonary complications that may be contributing to her respiratory distress.
Concurrent with addressing her respiratory issues, the patient's neurological status reveals subtle changes. She exhibits mild confusion and a decrease in her Glasgow Coma Scale score from 15 to 13, indicating a potential impact of her elevated blood pressure and worsening HELLP syndrome on her central nervous system. A CT scan of the head is performed to exclude any intracranial hemorrhage or cerebral edema, which are critical considerations in severe preeclampsia. The results of the CT scan show no acute intracranial pathology, suggesting that her neurologic changes are likely due to the systemic effects of her condition.
As these developments unfold, the multidisciplinary team conducts a careful reassessment of the patient's treatment plan. They implement a more aggressive antihypertensive strategy, adjusting her medication regimen to better control her blood pressure while minimizing the risk of further complications. They also continue to monitor her closely for any signs of worsening organ dysfunction, maintaining a delicate balance between managing her current symptoms and preventing further deterioration. The focus remains on stabilizing the patient, with plans for an interdisciplinary meeting to discuss possible escalation of care should her condition not improve. This adaptive approach highlights the importance of continuous monitoring and rapid response in managing complex and evolving cases of preeclampsia with HELLP syndrome.